Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP IT UP a BIT: Insulin Pen vs Syringe in Elderly T2DM
NCT01240200Phase 4Completed
- Sponsor
- Emory University
- Start
- Jan 2011
- Primary completion
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Emory University. Primary endpoints: Diabetes Treatment Satisfaction Questionnaire: Status at 12 weeks and Diabetes Treatment Satisfaction Questionnaire: Change at 24 weeks. Started Jan 2011; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01240200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240200.